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CREB is a 43 kDa basic leucine zipper nuclear protein that is ubiquitously expressed and conserved from Drosophila to humans. Transcriptional activation by CREB is mediated through its interaction with a consensus octanucleotide sequence (TGANNTCA) termed the cyclic AMP response element or CRE, located in the promoter region of target genes. CREB constitutively binds to the CRE sequence as a heterodimer or a homodimer. The transcriptional activity of CREB is in part regulated by phosphorylation of the protein at a specific residue, serine 133.
1,2 Stimulation of myeloid cells by granulocytemacrophage colony stimulating factor leads to the phosphorylation of CREB at serine 133 through an MEKK and pp90RSK (ribosomal S6 kinase)-dependent pathway. 3 CREB has previously been shown to be upregulated in the majority of acute leukemias, both at diagnosis and relapse. In contrast, CREB expression was found to be lower in bone marrow cells of patients with acute leukemia in remission and in the marrow of healthy donors. 4 We previously studied the biological consequences of CREB-overexpression in myeloid leukemia cells and identified CREB as a proto-oncogene involved in transformation by promoting abnormal proliferation and survival of myeloid cells. Transgenic mice in which CREB is overexpressed in the myeloid lineage developed myeloproliferative disease/myelodysplastic syndrome after 1 year. 5 Although CREB is implicated in the development of leukemia, the mechanism by which CREB-overexpression leads to a malignant phenotype remains elusive and most likely involves multiple target genes. It is plausible that the overabundance of CREB, and thus phosphorylated CREB, leads to enhanced binding of CREB to CRE sequences in the promoter regions of genes involved in cell proliferation and survival. To this end, we sought to investigate possible CREB target genes to understand the downstream pathways mediating transformation by CREB in hematopoietic cells. In this paper, we report that microarray analysis identified Meis1 as a significantly upregulated gene in CREB-overexpressing myeloid cells.
Meis1 is a member of the TALE (three amino-acid loop extension) family of transcription factors. It is closely related to the homeodomain-containing transcription factor family known
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K562+570b K562+570a control_a control_b Figure 1 Hierarchical clustering of the 896 CREB signature genes on the three CREB-overexpressing (left three lanes) and two control microarrays (right two lanes) from the human K562 myeloid leukemia cell line. Each row represents a gene and each column a sample. For each of the row-wise and column-wise hierarchical clustering, we identified two groups, turquoise (the upregulated genes in the CREBoverexpressed cells) and blue (the downregulated genes in the CREBoverexpressed cells). The heatmap represents the gene coexpression profiles and 'red' represents overexpression and 'green' for underexpression.
Letters to the Editor as the hox genes. This diverse family of transcription factors, including Meis1, HoxA9 and Pbx1, are normally expressed in primitive bone marrow cells. Meis1 forms multimeric complexes with HoxA9, and sometimes Pbx1, which then bind to target sequences of DNA to activate gene transcription. Although the expression of these transcription factors is critical for normal development of myeloid cells, the aberrant expression of these proteins has been implicated in the development of leukemia. During myelopoiesis, Meis1 expression decreases as cells differentiate. Meis1 is expressed in immature CD34 þ lineage negative hematopoietic cells but not in more differentiated CD34À lineage positive cells. Meis1 overexpression promotes self-renewal of the progenitor cell and inhibits G-CSFdependent differentiation into granulocytes. 6 The Meis1 promoter contains a CRE half-site element.
7 CREB-overexpression may disrupt the requisite decline in Meis1 protein expression that Letters to the Editor allows the differentiation of myeloid progenitor cells in response to cytokines. Here, we report that Meis1 is regulated downstream of CREB in normal hematopoietic cells, leukemia cell lines and primary leukemia cells.
Mouse Spleen Relative Gene Expression by qRT-PCR
To identify potential downstream target genes, we performed microarray analysis with RNA from K562 cells stably expressing CREB. CREB signature genes were identified by comparing the gene expression data of CREB-overexpressing cells and control parental cells (Figure 1 ). Hierarchical clustering of 896 genes was determined from three microarray experiments performed in triplicate with RNA from CREB-overexpressing K562 cells. The analysis demonstrated genes that clearly separated into two groups, upregulated genes and downregulated genes. Approximately 896 genes were found to be differentially expressed in the CREB-overexpressing cells compared to control parental cells. Of 896 differentially expressed genes, 702 were upregulated and they included two members of the MEIS1 family of genes and two members of the PBX1 family of genes, which have been reported to be critical for hematopoietic stem cell self-renewal and leukemogenesis. Based on these data, Meis1, an important transcription factor in hematopoiesis, was found to be upregulated 40-fold in CREB-overexpressing cells compared to controls.
We evaluated the same CREB-overexpressing acute myeloid leukemia (AML) cell lines for protein and RNA expression of CREB and Meis1. To detect Meis1 protein, we performed western blot analysis with lysates from two separate clones of K562 cells stably transfected with CREB cDNA and parental control cells. Western blot analysis revealed a higher level of CREB and Meis1 expression in the CREB-overexpressing cell lines than in the control cell line (Figure 2a ). Densitometry confirmed twofold higher expression of CREB in the transfectants compared to the parental control, similar to previously published results. 4, 5 Meis1 expression was threefold higher in the CREB-overexpressing cells compared to the parental control cells. We also obtained total RNA from K562 CREB-overexpressing cells and performed quantitative real-time PCR (qRT-PCR). In CREB-overexpressing cells, Meis1 RNA expression was 5-to10-fold higher than in the control cells (Po0.05; Figure 2b ).
To examine whether myeloid cells from CREB transgenic mice also had increased Meis1 expression, we isolated Gr-1/ Mac-1 þ bone marrow and spleen cells from transgenic mice that overexpressed CREB in myeloid cells and age-matched littermate control mice. 5 We performed western blot analysis to examine protein expression of CREB and Meis1 (Figure 2c ). The transgenic mouse Gr-1/Mac-1 þ cells expressed CREB and Meis1 at levels two-to threefold greater than control cells. Having determined that myeloid cells from CREB transgenic mice overexpressed Meis1 at the protein level, we sought to examine the expression of CREB and Meis1 at the RNA level. Gr-1/Mac-1 þ spleen cells were isolated using fluorescence activated cell sorting. Gr-1/Mac-1 þ cells from CREB transgenic mice showed a fivefold increase in the expression of Meis1 (Figure 2d) .
Next, we examined the levels of CREB in bone marrow samples from patients with AML at diagnosis. Three bone marrow samples were screened for CREB protein and RNA expression as previously described. 4 Increased levels of Meis1 protein were observed in a dose-dependent manner that correlated with CREB expression in all three of the patient samples compared to controls (Figure 2e ). We also isolated RNA from the bone marrow from a CREB þ patient with AML at diagnosis. Peripheral blood stem cells (CD34 þ cells) from a healthy donor were used as controls. Quantitative RT-PCR was performed to determine the expression of both CREB and Meis1.
The CREB þ AML cells showed a fivefold increase in the expression of CREB and over 30-fold increase in the expression of Meis1 when compared with normal CD34 þ stem cells (Figure 2f ). Our results demonstrated that Meis1 protein and RNA expression is increased in CREB-overexpressing cell lines, transgenic mice myeloid cells and AML patient bone marrow cells. Our results suggest that CREB-overexpression may lead to persistent expression of Meis1 and thus block differentiation of primitive hematopoietic progenitor cells, contributing to transformation and the development of acute leukemia.
